Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries
在低收入和中等收入国家,同时使用草药和利托那韦增强的COVID-19蛋白酶抑制剂可能存在药代动力学相互作用
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1210579
Smith, Dallas J; Bi, Huichang; Hamman, Josias; Ma, Xiaochao; Mitchell, Constance; Nyirenda, Kumbukani; Monera-Penduka, Tsitsi; Oketch-Rabah, Hellen; Paine, Mary F; Pettit, Syril; Pheiffer, Wihan; Van Breemen, Richard B; Embry, Michelle